Estimates Revisions OSE Immunotherapeutics Deutsche Boerse AG
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:02:47 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 3.156 EUR | +0.96% |
|
+0.57% | -39.77% |
| 08-19 | Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine | RE |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
- Consensus OSE Immunotherapeutics
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
